TABLE 6. Direct Medical Care Use by PSC Severity by Barrier Receiveda.
| Patients, % | ||||||
|---|---|---|---|---|---|---|
| Mild | Moderate | Severe | ||||
| Medical Resource | SoC | CIB | SoC | CIB | SoC | CIB |
| STN | ||||||
| First visit | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Second visit | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Third visit | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Fourth visit | 14.3 | 8.7 | 16.7 | 50.0 | 0.0 | 0.0 |
| Physician (first visit) | 3.6 | 4.3 | 8.3 | 0.0 | 0.0 | 0.0 |
| Ostomy belt | 14.4 | 17.0 | 25.0 | 13.0 | 0.0 | 0.0 |
| Facility fee (x3)b | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Facility fee (x1)b | 14.0 | 8.7 | 16.7 | 50.0 | 0.0 | 0.0 |
| Adhesive spray | 21.0 | 13.0 | 42.0 | 25.0 | 100.0 | 0.0 |
| Adhesive remover | 32.1 | 43.5 | 25.0 | 12.5 | 0.0 | 0.0 |
| Topical antibiotic | 3.6 | 8.8 | 0.0 | 0.0 | 0.0 | 0.0 |
| Ostomy powder | 43.0 | 35.0 | 58.0 | 50.0 | 0.0 | 100.0 |
| Film wipes | 36.0 | 13.0 | 50.0 | 38.0 | 0.0 | 100.0 |
Abbreviations: CIB, ceramide-infused skin barrier; SoC, standard of care; STN, stomal therapy nurse.
aValues are taken from the ADVOCATE study; percentages estimated based on subjects enrolled in ADVOCATE. A total of 28, 12, and 1 SoC patients experienced mild, moderate, and severe PSCs, respectively; corresponding values for ceramide-infused skin barrier were 23, 8, and 1, respectively.
bFacility fee (x3) is the facility fee associated with the first 3 STN visits. Facility fee (x1) is the facility fee associated with the fourth STN visit.